STRUCTURAL INTERACTIONS BETWEEN RETROVIRAL GAG PROTEINS EXAMINED BY CYSTEINE CROSS-LINKING

被引:32
作者
HANSEN, MST
BARKLIS, E
机构
[1] OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,PORTLAND,OR 97201
[2] OREGON HLTH SCI UNIV,DEPT MOLEC MICROBIOL & IMMUNOL,PORTLAND,OR 97201
关键词
D O I
10.1128/JVI.69.2.1150-1159.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have examined structural interactions between Gag proteins within Moloney murine leukemia virus (M-MuLV) particles by making use of the cysteine-specific cross-linking agents iodine and bis-maleimido hexane. Virion-associated wild-type M-MuLV Pr65(Gag) proteins in immature particles were intermolecularly cross-linked at cysteines to form pr65(Gag) oligomers, from dimers to pentamers or hexamers. Following a systematic approach of cysteine-to-serine mutagenesis, we have shown that cross-linking of pr65(Gag) occurred at cysteines of the nucleocapsid (NC) Cys-His motif, suggesting that the Cys-His motifs within virus particles are packed in close proximity. The M-MuLV pr65(Gag) protein did not cross-link to the human immunodeficiency virus pr55(Gag) protein when the two molecules were coexpressed, indicating either that they did not coassemble or that heterologous Gag proteins were not in close enough proximity to be cross linked. Using an assembly-competent, protease-minus, cysteine-minus pr65(Gag) protein as a template, novel cysteine residues were generated in the M-MuLV capsid domain major homology region (MHR). Cross-linking of proteins containing MHR cysteines showed above-background levels of Gag Gag dimers but also identified a novel cellular factor, present in virions, that cross-linked to MHR residues. Although the NC cysteine mutation was compatible with M-MuLV particle assembly, deletions of the NC domain were not tolerated. These results suggest that the Cys-His motif is held in close proximity within immature M-MuLV particles by interactions between CA domains and/or non-Cys-His motif domains of the NC.
引用
收藏
页码:1150 / 1159
页数:10
相关论文
共 49 条
[31]   CONSTRUCTION AND USE OF A HUMAN-IMMUNODEFICIENCY-VIRUS VECTOR FOR ANALYSIS OF VIRUS INFECTIVITY [J].
PAGE, KA ;
LANDAU, NR ;
LITTMAN, DR .
JOURNAL OF VIROLOGY, 1990, 64 (11) :5270-5276
[32]   DETERMINATION OF TRANSMEMBRANE PROTEIN-STRUCTURE BY DISULFIDE CROSS-LINKING - THE ESCHERICHIA-COLI TAR RECEPTOR [J].
PAKULA, AA ;
SIMON, MI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :4144-4148
[33]   CHEMICAL CROSSLINKING OF PROTEINS IN AVIAN-SARCOMA AND LEUKEMIA VIRUSES [J].
PEPINSKY, RB ;
CAPPIELLO, D ;
WILKOWSKI, C ;
VOGT, VM .
VIROLOGY, 1980, 102 (01) :205-210
[34]  
PEPINSKY RB, 1983, J BIOL CHEM, V258, P1229
[35]   MYRISTYLATION SITE IN PR65GAG IS ESSENTIAL FOR VIRUS PARTICLE FORMATION BY MOLONEY MURINE LEUKEMIA-VIRUS [J].
REIN, A ;
MCCLURE, MR ;
RICE, NR ;
LUFTIG, RB ;
SCHULTZ, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (19) :7246-7250
[36]   DNA SEQUENCING WITH CHAIN-TERMINATING INHIBITORS [J].
SANGER, F ;
NICKLEN, S ;
COULSON, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) :5463-5467
[37]   HIGH-FREQUENCY OF ABERRANT EXPRESSION OF MOLONEY MURINE LEUKEMIA-VIRUS IN CLONAL INFECTIONS [J].
SHIELDS, A ;
WITTE, ON ;
ROTHENBERG, E ;
BALTIMORE, D .
CELL, 1978, 14 (03) :601-609
[38]   NUCLEOTIDE-SEQUENCE OF MOLONEY MURINE LEUKEMIA-VIRUS [J].
SHINNICK, TM ;
LERNER, RA ;
SUTCLIFFE, JG .
NATURE, 1981, 293 (5833) :543-548
[39]   MURINE LEUKEMIA-VIRUS MUTANTS WITH TEMPERATURE-SENSITIVE DEFECTS IN PRECURSOR POLYPEPTIDE CLEAVAGE [J].
STEPHENSON, JR ;
TRONICK, SR ;
AARONSON, SA .
CELL, 1975, 6 (04) :543-550
[40]   PROPERTIES OF AVIAN RETROVIRUS PARTICLES DEFECTIVE IN VIRAL PROTEASE [J].
STEWART, L ;
SCHATZ, G ;
VOGT, VM .
JOURNAL OF VIROLOGY, 1990, 64 (10) :5076-5092